Curated

Reading time: 5 seconds

Telomere Extension Therapy Shows Promise in Phase II Human Trials

A new gene therapy approach successfully extended telomeres in 67% of participants with no adverse effects after 12 months.

Latest on Other Topics

Reading time: 11 minutes and 40 seconds

Reading time: 3 minutes and 15 seconds

Reading time: 5 minutes and 50 seconds

Reading time: 12 minutes and 30 seconds

Researchers at Stanford identify neural pathways that remain highly plastic well into old age, challenging long-held assumptions.

Reading time: 5 seconds

Emerging evidence suggests that semaglutide and tirzepatide may reduce inflammation markers linked to biological aging.

Reading time: 5 seconds

Latest on Other Topics

Reading time: 5 minutes and 20 seconds

Reading time: 9 seconds

Reading time: 10 seconds

Reading time: 9 seconds